1. Home
  2. TRX vs RVPH Comparison

TRX vs RVPH Comparison

Compare TRX & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRX
  • RVPH
  • Stock Information
  • Founded
  • TRX 1990
  • RVPH 2006
  • Country
  • TRX Canada
  • RVPH United States
  • Employees
  • TRX N/A
  • RVPH N/A
  • Industry
  • TRX
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRX
  • RVPH Health Care
  • Exchange
  • TRX Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • TRX 90.8M
  • RVPH 88.0M
  • IPO Year
  • TRX N/A
  • RVPH N/A
  • Fundamental
  • Price
  • TRX $0.32
  • RVPH $1.76
  • Analyst Decision
  • TRX Strong Buy
  • RVPH Strong Buy
  • Analyst Count
  • TRX 2
  • RVPH 5
  • Target Price
  • TRX $1.63
  • RVPH $11.40
  • AVG Volume (30 Days)
  • TRX 405.4K
  • RVPH 1.5M
  • Earning Date
  • TRX 04-11-2025
  • RVPH 11-14-2024
  • Dividend Yield
  • TRX N/A
  • RVPH N/A
  • EPS Growth
  • TRX N/A
  • RVPH N/A
  • EPS
  • TRX 0.01
  • RVPH N/A
  • Revenue
  • TRX $44,282,000.00
  • RVPH N/A
  • Revenue This Year
  • TRX $69.93
  • RVPH N/A
  • Revenue Next Year
  • TRX $21.44
  • RVPH N/A
  • P/E Ratio
  • TRX $61.08
  • RVPH N/A
  • Revenue Growth
  • TRX 16.51
  • RVPH N/A
  • 52 Week Low
  • TRX $0.28
  • RVPH $0.60
  • 52 Week High
  • TRX $0.49
  • RVPH $4.59
  • Technical
  • Relative Strength Index (RSI)
  • TRX 50.90
  • RVPH 43.34
  • Support Level
  • TRX $0.30
  • RVPH $1.97
  • Resistance Level
  • TRX $0.33
  • RVPH $2.14
  • Average True Range (ATR)
  • TRX 0.01
  • RVPH 0.15
  • MACD
  • TRX 0.00
  • RVPH -0.03
  • Stochastic Oscillator
  • TRX 57.50
  • RVPH 15.96

About TRX TRX Gold Corporation

TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. Its projects include the Buckreef project, and Itetemia Gold project whereas, its exploration stage project consists of the Lunguya project and the Luhala project.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: